• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.

作者信息

Hideshima Teru, Podar Klaus, Chauhan Dharminder, Ishitsuka Kenji, Mitsiades Constantine, Tai Yu-Tzu, Hamasaki Makoto, Raje Noopur, Hideshima Hiromasa, Schreiner George, Nguyen Aaron N, Navas Tony, Munshi Nikhil C, Richardson Paul G, Higgins Linda S, Anderson Kenneth C

机构信息

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.

Scios Inc., 6500 Paseo Padre Parkway, Fremont, CA, 94555, USA.

出版信息

Oncogene. 2024 Sep;43(40):3018. doi: 10.1038/s41388-024-03147-5.

DOI:10.1038/s41388-024-03147-5
PMID:39209967
Abstract
摘要

相似文献

1
Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.编辑关注声明：p38丝裂原活化蛋白激酶抑制增强PS-341（硼替佐米）对多发性骨髓瘤细胞的细胞毒性。
Oncogene. 2024 Sep;43(40):3018. doi: 10.1038/s41388-024-03147-5.
2
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.p38丝裂原活化蛋白激酶抑制增强PS-341（硼替佐米）诱导的针对多发性骨髓瘤细胞的细胞毒性。
Oncogene. 2004 Nov 18;23(54):8766-76. doi: 10.1038/sj.onc.1208118.
3
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.BIRB 796通过抑制多发性骨髓瘤细胞系中的p38丝裂原活化蛋白激酶/Hsp27途径增强硼替佐米、热休克蛋白（Hsp）90抑制剂和地塞米松引发的细胞毒性，并抑制旁分泌肿瘤生长。
Br J Haematol. 2007 Feb;136(3):414-23. doi: 10.1111/j.1365-2141.2006.06443.x. Epub 2006 Dec 14.
4
Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.硼替佐米增强了洛美沙星对人多发性骨髓瘤细胞的疗效。
Anticancer Drugs. 2013 Jul;24(6):609-16. doi: 10.1097/CAD.0b013e3283615006.
5
Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.姜黄素增强硼替佐米对人多发性骨髓瘤H929细胞的细胞毒性作用：NF-κB/JNK的潜在作用
Int J Mol Sci. 2012;13(4):4831-4838. doi: 10.3390/ijms13044831. Epub 2012 Apr 16.
6
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications.p38丝裂原活化蛋白激酶抑制剂LY2228820增强硼替佐米诱导的细胞毒性并抑制多发性骨髓瘤中的破骨细胞生成；治疗意义
Br J Haematol. 2008 May;141(5):598-606. doi: 10.1111/j.1365-2141.2008.07044.x. Epub 2008 Apr 7.
7
Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.c-Met 敲低通过抑制 Akt/mTOR 活性增强人多发性骨髓瘤 U266 细胞对硼替佐米的敏感性。
APMIS. 2012 Mar;120(3):195-203. doi: 10.1111/j.1600-0463.2011.02836.x. Epub 2011 Nov 11.
8
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.三氧化二砷联合硼替佐米增强骨髓瘤细胞毒性作用可被 p38MAPK 抑制剂进一步增强。
Leuk Res. 2010 Jan;34(1):85-92. doi: 10.1016/j.leukres.2009.05.024. Epub 2009 Jul 15.
9
Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines.线粒体介导的钙离子调节紊乱是万珂（PS - 341/硼替佐米）对骨髓瘤细胞系细胞毒性的关键决定因素。
Cancer Res. 2005 May 1;65(9):3828-36. doi: 10.1158/0008-5472.CAN-04-3684.
10
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity.硼替佐米对人神经母细胞瘤的作用：对细胞毒性相关分子机制的分析
Mol Cancer. 2008 Jun 5;7:50. doi: 10.1186/1476-4598-7-50.